Loading organizations...
§ Venture Capital · Philadelphia, PA, USA
Venture capital firm investing in early-growth stage companies for health and wellness in India, focused on consumer well-being.
Key people at Alkemi Growth Capital.
Alkemi Growth Capital is a venture capital investment firm based in New Delhi, India, that provides equity financing and strategic operational support to early-growth stage companies. The firm primarily targets investments across the healthcare, health-tech, consumer wellness, life sciences, and diagnostics sectors operating within the broader Indian market. Alkemi Growth Capital launched its maiden investment vehicle with a target corpus of approximately $50 million to back emerging consumer well-being enterprises, subsequently opening an additional fund for investments in January 2023. The firm's active investment portfolio includes recognizable healthcare and wellness brands such as Doceree, Pee Safe, MedGenome, and HealthCube. Notable recent transactions include participating in a $35 million Series B funding round for Doceree in September 2023 and a $5.8 million financing round for Pee Safe. Alkemi Growth Capital was founded in 2017 by general partner Alka Goel.
Alkemi Growth Capital is a growth investment firm primarily focused on the healthcare and consumer wellness sectors in India. Their mission is to elevate the health and well-being of Indian consumers while delivering strong returns to shareholders. They invest mainly in early-stage and growth-stage companies that innovate in healthcare IT, digital health, FemTech, and wellness industries. By backing startups that enhance consumer wellness, Alkemi plays a significant role in nurturing the Indian health-tech ecosystem and supporting scalable innovations that address critical health challenges[1][2][3][4].
Founded in 2017 and based in New Delhi, Alkemi Growth Capital was established by key partners including Alka Goel, a former McKinsey partner with a strong background in healthcare and business strategy. The firm evolved with a clear focus on growth-stage investments in health and wellness startups, driven by a vision to improve healthcare delivery and consumer wellness in India. The leadership’s experience and commitment to healthcare fundamentals have shaped Alkemi’s targeted investment approach and its emphasis on impact alongside financial returns[1][3][4].
Alkemi Growth Capital rides the growing trend of digital health and wellness innovation in India, a market driven by increasing consumer health awareness, rising chronic diseases, and expanding technology adoption. The timing is favorable due to government initiatives supporting healthcare digitization and a surge in health-tech startups. Alkemi’s investments help accelerate the development and scaling of solutions that improve healthcare accessibility, quality, and consumer engagement, thereby influencing the broader ecosystem by setting benchmarks for impact-focused growth investing in health and wellness[1][2][3].
Looking ahead, Alkemi Growth Capital is poised to deepen its impact by continuing to back innovative health and wellness startups that can scale across India and potentially beyond. Trends such as personalized medicine, FemTech, mental wellness, and healthcare IT will likely shape their investment focus. As the Indian healthcare market matures and consumer wellness gains prominence, Alkemi’s influence as a growth investor with a mission-driven approach is expected to expand, fostering a healthier and more sustainable ecosystem.
This trajectory aligns with their founding vision of combining strong financial returns with meaningful improvements in consumer health, making Alkemi a key player in India’s evolving health-tech landscape[4][5].
Key people at Alkemi Growth Capital.
Alkemi Growth Capital has 18 tracked investments across 14 companies. The latest tracked deal is $5.0M Series B in StayVista in June 2025.
